Nikotiinireseptorit (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nikotiinireseptorit" in Finnish language version.

refsWebsite

Global rank Finnish rank

28nih.gov

4^th place

12^th place

17doi.org

2^nd place

10^th place

17worldcat.org

5^th place

9^th place

2sciencedirect.com

149^th place

237^th place

1biomedcentral.com

2,747^th place

1,855^th place

1oup.com

485^th place

642^nd place

1genenames.org

low place

1nature.com

234^th place

201^st place

biomedcentral.com

bmcgenomics.biomedcentral.com

Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848. doi:10.1186/s12864-019-6278-9. ISSN 1471-2164. Artikkelin verkkoversio.

doi.org

dx.doi.org

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755. doi:10.1152/physrev.00015.2008. ISSN 0031-9333. Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137. doi:10.1074/jbc.M115.646786. ISSN 0021-9258. Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313. doi:10.1146/annurev.pharmtox.48.113006.094742. ISSN 0362-1642. Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248. doi:10.1186/s12862-018-1341-8. ISSN 1471-2148. Artikkelin verkkoversio.
Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848. doi:10.1186/s12864-019-6278-9. ISSN 1471-2164. Artikkelin verkkoversio.
RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452. doi:10.1093/toxsci/kfs118. ISSN 1096-6080. Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968. doi:10.1371/journal.ppat.1008715. ISSN 1553-7366. Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538. doi:10.1371/journal.pone.0079653. ISSN 1932-6203. Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712. doi:10.1038/s41467-019-10723-x. ISSN 2041-1723. Artikkelin verkkoversio.
CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925. doi:10.1038/gim.2014.9. ISSN 1530-0366. Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020. doi:10.1016/j.apsb.2017.09.001. ISSN 2211-3835. Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327. doi:10.3389/fnsyn.2020.607959. ISSN 1663-3563. Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338. doi:10.1124/pr.119.018028. ISSN 0031-6997. Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444. doi:10.1124/mol.119.118786. ISSN 0026-895X. Artikkelin verkkoversio.
HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645. doi:10.1016/j.bbamem.2014.11.003. ISSN 0006-3002. Artikkelin verkkoversio.
HG Campello: Unlocking nicotinic selectivity via direct C‒H functionalization of (−)-cytisine. Chem, 2018, 4. vsk, nro 7, s. 1710–1725. doi:10.1016/j.chempr.2018.05.007. ISSN 2451-9294. Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658. doi:10.1021/cn500369h. ISSN 1948-7193. Artikkelin verkkoversio.

genenames.org

Gene group: Cholinergic receptors nicotinic subunits (CHRN) genenames.org. Viitattu 27.3.2021.

nature.com

CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925. doi:10.1038/gim.2014.9. ISSN 1530-0366. Artikkelin verkkoversio.

nih.gov

pubmed.ncbi.nlm.nih.gov

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755. doi:10.1152/physrev.00015.2008. ISSN 0031-9333. Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137. doi:10.1074/jbc.M115.646786. ISSN 0021-9258. Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313. doi:10.1146/annurev.pharmtox.48.113006.094742. ISSN 0362-1642. Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248. doi:10.1186/s12862-018-1341-8. ISSN 1471-2148. Artikkelin verkkoversio.
Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848. doi:10.1186/s12864-019-6278-9. ISSN 1471-2164. Artikkelin verkkoversio.
RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452. doi:10.1093/toxsci/kfs118. ISSN 1096-6080. Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968. doi:10.1371/journal.ppat.1008715. ISSN 1553-7366. Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538. doi:10.1371/journal.pone.0079653. ISSN 1932-6203. Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712. doi:10.1038/s41467-019-10723-x. ISSN 2041-1723. Artikkelin verkkoversio.
CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925. doi:10.1038/gim.2014.9. ISSN 1530-0366. Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020. doi:10.1016/j.apsb.2017.09.001. ISSN 2211-3835. Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327. doi:10.3389/fnsyn.2020.607959. ISSN 1663-3563. Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338. doi:10.1124/pr.119.018028. ISSN 0031-6997. Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444. doi:10.1124/mol.119.118786. ISSN 0026-895X. Artikkelin verkkoversio.
HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645. doi:10.1016/j.bbamem.2014.11.003. ISSN 0006-3002. Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658. doi:10.1021/cn500369h. ISSN 1948-7193. Artikkelin verkkoversio.

ncbi.nlm.nih.gov

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755. doi:10.1152/physrev.00015.2008. ISSN 0031-9333. Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137. doi:10.1074/jbc.M115.646786. ISSN 0021-9258. Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313. doi:10.1146/annurev.pharmtox.48.113006.094742. ISSN 0362-1642. Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248. doi:10.1186/s12862-018-1341-8. ISSN 1471-2148. Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968. doi:10.1371/journal.ppat.1008715. ISSN 1553-7366. Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538. doi:10.1371/journal.pone.0079653. ISSN 1932-6203. Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712. doi:10.1038/s41467-019-10723-x. ISSN 2041-1723. Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020. doi:10.1016/j.apsb.2017.09.001. ISSN 2211-3835. Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327. doi:10.3389/fnsyn.2020.607959. ISSN 1663-3563. Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338. doi:10.1124/pr.119.018028. ISSN 0031-6997. Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444. doi:10.1124/mol.119.118786. ISSN 0026-895X. Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658. doi:10.1021/cn500369h. ISSN 1948-7193. Artikkelin verkkoversio.

oup.com

academic.oup.com

RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452. doi:10.1093/toxsci/kfs118. ISSN 1096-6080. Artikkelin verkkoversio.

sciencedirect.com

HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645. doi:10.1016/j.bbamem.2014.11.003. ISSN 0006-3002. Artikkelin verkkoversio.
HG Campello: Unlocking nicotinic selectivity via direct C‒H functionalization of (−)-cytisine. Chem, 2018, 4. vsk, nro 7, s. 1710–1725. doi:10.1016/j.chempr.2018.05.007. ISSN 2451-9294. Artikkelin verkkoversio.

worldcat.org

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755. doi:10.1152/physrev.00015.2008. ISSN 0031-9333. Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137. doi:10.1074/jbc.M115.646786. ISSN 0021-9258. Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313. doi:10.1146/annurev.pharmtox.48.113006.094742. ISSN 0362-1642. Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248. doi:10.1186/s12862-018-1341-8. ISSN 1471-2148. Artikkelin verkkoversio.
Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848. doi:10.1186/s12864-019-6278-9. ISSN 1471-2164. Artikkelin verkkoversio.
RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452. doi:10.1093/toxsci/kfs118. ISSN 1096-6080. Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968. doi:10.1371/journal.ppat.1008715. ISSN 1553-7366. Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538. doi:10.1371/journal.pone.0079653. ISSN 1932-6203. Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712. doi:10.1038/s41467-019-10723-x. ISSN 2041-1723. Artikkelin verkkoversio.
CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925. doi:10.1038/gim.2014.9. ISSN 1530-0366. Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020. doi:10.1016/j.apsb.2017.09.001. ISSN 2211-3835. Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327. doi:10.3389/fnsyn.2020.607959. ISSN 1663-3563. Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338. doi:10.1124/pr.119.018028. ISSN 0031-6997. Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444. doi:10.1124/mol.119.118786. ISSN 0026-895X. Artikkelin verkkoversio.
HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645. doi:10.1016/j.bbamem.2014.11.003. ISSN 0006-3002. Artikkelin verkkoversio.
HG Campello: Unlocking nicotinic selectivity via direct C‒H functionalization of (−)-cytisine. Chem, 2018, 4. vsk, nro 7, s. 1710–1725. doi:10.1016/j.chempr.2018.05.007. ISSN 2451-9294. Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658. doi:10.1021/cn500369h. ISSN 1948-7193. Artikkelin verkkoversio.